3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
67
Leukemia
28
Precursor Cell Lymphoblastic Leukemia-Lymphoma
26
Lymphoma
20
Lymphoma, Follicular
14
Congenital Abnormalities
14
Lymphoma, Non-Hodgkin
13
Recurrence
12
Lymphoma, Large B-Cell, Diffuse
12
Leukemia, Monocytic, Acute
12
Myelodysplastic Syndromes
11
Leukemia, Lymphocytic, Chronic, B-Cell
9
Leukemia, Erythroblastic, Acute
9
Prostatic Neoplasms
8
Lymphoma, Large-Cell, Immunoblastic
8
Leukemia, Myelomonocytic, Acute
8
Leukemia, Megakaryoblastic, Acute
8
Leukemia, Biphenotypic, Acute
8
Lymphoma, Mantle-Cell
7
Hodgkin Disease
5
Burkitt Lymphoma
5
Blast Crisis
5
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Promyelocytic, Acute
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Sarcoma, Myeloid
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Interventions
Cyclophosphamide
21
Cytarabine
15
blinatumomab
13
fludarabine
12
Azacitidine
10
venetoclax
9
fludarabine phosphate
9
Blood Specimen Collection
8
Methotrexate
7
Lenalidomide
7
Dexamethasone
7
Rituximab
6
Mercaptopurine
6
Daunorubicin
6
Vincristine
5
daratumumab
4
Whole-Body Irradiation
4
Melphalan
4
Etoposide
4
Busulfan
4
obinutuzumab
3
Radiotherapy
3
Neoadjuvant Therapy
3
Maintenance
3
Liquid Biopsy
3
Immunotherapy, Adoptive
3
Idarubicin
3
Granulocyte Colony-Stimulating Factor
3
Drug Therapy
3
Doxorubicin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasm, Residual
×
Mitoxantrone
×
Clear all
NCT02724163
2021-10-08
Myechild01
University of Birmingham
Phase 3
Recruiting
700 enrolled